IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Brooks Laboratories IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 63.00 Cr. The company is based in Punjab and caters to Pharmaceutical sector. D And A Financial Services is the merchant banker of Brooks Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 25th November 2010.
Brooks Laboratories IPO posted revenues of ₹ 52.53 Cr. and PAT of ₹ 1.12 Cr. in FY25 on annualised basis.
Revenue:
₹ 52.53 Cr.
EBITDA Margin:
44.62
% 
Net Worth: ₹ 18.93 Cr.
Market Capitalisation:
[●]
P/E:
17.33 times
P/BV: [●]
EV/EBITDA: 0.33 times
Financial results of Brooks Laboratories IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY11 | FY10 | FY09 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 20.69 | 17.87 | 14.89 | ||
| Net Worth | 18.93 | 13.56 | 8.36 | ||
| Total Debt | 8.66 | 11.82 | 16.06 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
52.53 | 45.06 | 44.92 | ||
EBITDA
EBITDA on annualised basis |
23.44 | 26.18 | 43.17 | ||
PAT
PAT on annualised basis |
1.12 | 4.70 | 5.76 | ||
Brooks Laboratories IPO PAT Margin is 2.13 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Brooks Laboratories IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY11 | FY10 | FY09 |
|---|---|---|---|
| EBITDA Margin (%) | 44.62 | 58.10 | 96.10 |
| PAT Margin (%) | 2.13 | 10.43 | 12.82 |
| EPS (₹) | 7.00 | 5.32 | 3.01 |
| ROE (%) | 5.92 | 34.66 | 68.90 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 5.41 | 26.30 | 38.68 |
| Debt to Equity | 0.46 | 0.87 | 1.92 |
The market Capitalisation of Brooks Laboratories IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Brooks Laboratories IPO prospectus highlights an Return on Equity (ROE) of 5.92 % , Return on Assets (ROA) of 5.41 %, and an EBITDA Margin of 44.62 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Brooks Laboratories IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Brooks Laboratories IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Brooks Laboratories IPO has a Price-to-Earnings (PE) ratio of 17.33 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Brooks Laboratories IPO reported revenue of ₹ 53.20 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Brooks Laboratories IPO provide insights into sales growth, market demand, and business scalability.
Brooks Laboratories recorded an EBITDA of ₹ 23.44 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Brooks Laboratories Profit After Tax (PAT) is ₹ 1.12 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 52.53 Cr.
EBITDA Margin:
44.62
%
Net Worth: ₹ 18.93 Cr.
Market Capitalisation:
[●]
P/E:
17.33 times
P/BV: [●]
EV/EBITDA:
[●]
Brooks Laboratories operates in Pharmaceutical and Business Of Pharmaceutical Contract Research & Manufacturing. The Issue is listed on BSE,NSE in Sep, 2011. Brooks Laboratories IPO size was 63.00 with Issue price of 100.00 .
Merchant Banker(s) of Brooks Laboratories IPO: D And A Financial Services Private Limited
Brooks Laboratories IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Brooks Laboratories IPO listed at a listing price of 60.20 against the offer price of 100.00.
The current market price of Brooks Laboratories is 152.78.
Why Us?
